Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

July 31, 2022

Conditions
Clinical Trial
Interventions
DIETARY_SUPPLEMENT

"Analimentary detoxication (ANADETO) weight loss based on very-low-calorie-diet"

calorie restriction to 50-100 kcal/day with fat-free vegetables (tomatoes and cucumbers) with mandatory salt intake to 5-6 gr/day, hot water drinking 1000-1500 ml/day, walking at least 2,000 steps/day after normalized body temperature, and sexual self-restraint. The walking provided to promote of blood circulation and decrease in metabolic intoxication. The weight loss method lasted 14 days. Then the patients followed for 4-week a diet where they ate one meal a day without any food restriction.

Trial Locations (1)

010000

Kuat Pernekulovich Oshakbayev, Astana

All Listed Sponsors
lead

University Medical Center, Kazakhstan

OTHER

NCT05635539 - Weight Loss in Patients With COVID-19 and Influenza in Comorbidity With NCDs: a Pilot Prospective Clinical Trial | Biotech Hunter | Biotech Hunter